These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 3390495)
41. Postdexamethasone prolactin and cortisol: a biological state variable in depression. Klein HE; Seibold B; Bender W; Nedopil N; Albus M; Schmauss M Acta Psychiatr Scand; 1984 Sep; 70(3):239-47. PubMed ID: 6496148 [TBL] [Abstract][Full Text] [Related]
42. Saliva cortisol levels following dexamethasone administration in endogenously depressed patients. Poland RE; Rubin RT Life Sci; 1982 Jan; 30(2):177-81. PubMed ID: 7054643 [TBL] [Abstract][Full Text] [Related]
43. Differences in platelet monoamine oxidase activity in subgroups of schizophrenic and depressive disorders. Orsulak PJ; Schildkraut JJ; Schatzberg AF; Herzog JM Biol Psychiatry; 1978 Dec; 13(6):637-47. PubMed ID: 737252 [TBL] [Abstract][Full Text] [Related]
44. Personality traits and monoamine oxidase activity in platelets in depressed patients. Perris C; Eisemann M; von Knorring L; Oreland L; Perris H Neuropsychobiology; 1984; 12(4):201-5. PubMed ID: 6535064 [TBL] [Abstract][Full Text] [Related]
45. Low levels of somatostatin in human CSF mark depressive episodes. Agren H; Lundqvist G Psychoneuroendocrinology; 1984; 9(3):233-48. PubMed ID: 6149588 [TBL] [Abstract][Full Text] [Related]
46. Pretreatment dexamethasone suppression test as a predictor of response to phenelzine. Janicak PG; Pandey GN; Sharma R; Boshes R; Bresnahan D; Davis JM J Clin Psychiatry; 1987 Dec; 48(12):480-2. PubMed ID: 3693333 [TBL] [Abstract][Full Text] [Related]
47. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study. Stokes PE; Stoll PM; Koslow SH; Maas JW; Davis JM; Swann AC; Robins E Arch Gen Psychiatry; 1984 Mar; 41(3):257-67. PubMed ID: 6367690 [TBL] [Abstract][Full Text] [Related]
48. Platelet MAO activity in posttraumatic stress disorder. Davidson J; Lipper S; Kilts CD; Mahorney S; Hammett E Am J Psychiatry; 1985 Nov; 142(11):1341-3. PubMed ID: 4061693 [TBL] [Abstract][Full Text] [Related]
49. Comparison of whole blood serotonin and platelet MAO in children with schizophrenia and major depressive disorder. Rogeness GA; Mitchell EL; Custer GJ; Harris WR Biol Psychiatry; 1985 Mar; 20(3):270-5. PubMed ID: 3978162 [TBL] [Abstract][Full Text] [Related]
51. Relationship between response to phenelzine and MAO inhibition in a clinical trial of phenelzine, amitriptyline and placebo. Raft D; Davidson J; Wasik J; Mattox A Neuropsychobiology; 1981; 7(3):122-6. PubMed ID: 7231652 [TBL] [Abstract][Full Text] [Related]
52. The effect of isocarboxazid on platelet MAO activity. Davidson J; White H Biol Psychiatry; 1983 Sep; 18(9):1075-9. PubMed ID: 6640004 [No Abstract] [Full Text] [Related]
53. Prediction of the DST results in depressives by means of urinary-free cortisol excretion, dexamethasone levels, and age. Maes M; Jacobs MP; Suy E; Minner B; Raus J Biol Psychiatry; 1990 Aug; 28(4):349-57. PubMed ID: 2397250 [TBL] [Abstract][Full Text] [Related]